Literature DB >> 7803371

Cognitive deterioration from long-term abuse of dextromethorphan: a case report.

A Hinsberger1, V Sharma, D Mazmanian.   

Abstract

Dextromethorphan (DM), the dextrorotatory isomer of 3-hydroxy-N-methylmorphinan, is the main ingredient in a number of widely available, over-the-counter antitussives. Initial studies (Bornstein 1968) showed that it possessed no respiratory suppressant effects and no addiction liability. Subsequently, however, several articles reporting abuse of this drug have appeared in the literature. The drug is known to cause a variety of acute toxic effects, ranging from nausea, restlessness, insomnia, ataxia, slurred speech and nystagmus to mood changes, perceptual alterations, inattention, disorientation and aggressive behavior (Rammer et al 1988; Katona and Watson 1986; Isbell and Fraser 1953; Devlin et al 1985; McCarthy 1971; Dodds and Revai 1967; Degkwitz 1964; Hildebrand et al 1989). There have also been two reported fatalities from DM overdoses (Fleming 1986). However, there are no reports describing the effects of chronic abuse. This report describes a case of cognitive deterioration resulting from prolonged use of DM.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7803371      PMCID: PMC1188627     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  11 in total

1.  Actions and addiction liabilities of dromoran derivatives in man.

Authors:  H ISBELL; H F FRASER
Journal:  J Pharmacol Exp Ther       Date:  1953-04       Impact factor: 4.030

2.  Dependence on dextromethorphan hydrobromide.

Authors:  P M Fleming
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-06

3.  Psychoactive abuse potential of Robitussin-DM.

Authors:  J Helfer; O M Kim
Journal:  Am J Psychiatry       Date:  1990-05       Impact factor: 18.112

4.  Dextromethorphan for treatment of complex partial seizures.

Authors:  R S Fisher; B J Cysyk; R P Lesser; M J Pontecorvo; J T Ferkany; P R Schwerdt; J Hart; B Gordon
Journal:  Neurology       Date:  1990-03       Impact factor: 9.910

5.  Fatal intoxication by dextromethorphan: a report on two cases.

Authors:  L Rammer; P Holmgren; H Sandler
Journal:  Forensic Sci Int       Date:  1988-06       Impact factor: 2.395

6.  Some less familiar drugs of abuse.

Authors:  J P McCarthy
Journal:  Med J Aust       Date:  1971-11-20       Impact factor: 7.738

7.  [Apropos of a case of voluntary drug poisoning dextromethorphan hydrobromide].

Authors:  S Bornstein; M Czermak; J Postel
Journal:  Ann Med Psychol (Paris)       Date:  1968-03       Impact factor: 0.380

8.  Dextromethorphan danger.

Authors:  B Katona; S Wason
Journal:  N Engl J Med       Date:  1986-04-10       Impact factor: 91.245

9.  Cerebellar atrophy due to chronic bromisovalum abuse demonstrated by computed tomography.

Authors:  A J Van Balkom; B J Van de Wetering; D L Tavy; R E Hekster; T C van Woerkom
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-04       Impact factor: 10.154

10.  Determination of dextromethorphan metabolizer phenotype in healthy volunteers.

Authors:  M Hildebrand; W Seifert; A Reichenberger
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

View more
  3 in total

1.  Impairments in water maze learning of aged rats that received dextromethorphan repeatedly during adolescent period.

Authors:  Tie Yuan Zhang; Hee Jeong Cho; Seoul Lee; Jong-Ho Lee; Si Ho Choi; Vitaly Ryu; Sang Bae Yoo; Joo Young Lee; Dong Goo Kim; Jeong Won Jahng
Journal:  Psychopharmacology (Berl)       Date:  2006-10-05       Impact factor: 4.530

2.  Perioperative Dextromethorphan as an Adjunct for Postoperative Pain: A Meta-analysis of Randomized Controlled Trials.

Authors:  Michael R King; Karim S Ladha; Amanda M Gelineau; T Anthony Anderson
Journal:  Anesthesiology       Date:  2016-03       Impact factor: 7.892

Review 3.  Antitussives and substance abuse.

Authors:  Jarrett M Burns; Edward W Boyer
Journal:  Subst Abuse Rehabil       Date:  2013-11-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.